Malignant Glioma
Malignant glioma is a type of aggressive brain tumor that arises from glial cells in the brain, often leading to severe neurological symptoms and requiring prompt treatment.
Temozolomide for Non-enhancing Adult Brainstem Gliomas
We are studying the effects of Temozolomide chemotherapy in adults with specific types of brainstem gliomas. This trial aims to see how well it works for tumors that show an infiltrative pattern of growth.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Brain Stem Glioma
Brain stem glioma is a type of tumor located in the brain stem, which can affect vital functions such as breathing and heart rate, and is often associated with significant neurological symptoms.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
CHU Amiens - Groupe Hospitalier Sud
Oncologie Médicale et Neurologie
Amiens, France
Institut de Cancérologie de l'Ouest - site d'Angers
Oncologie Médicale
Angers, France
Centre Hospitalier Regional Et Universitaire De Brest
Oncologie Médicale
Brest, France
Sponsor: Assistance Publique Hopitaux De Paris
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.